Raymond Anderson
Direktor/Vorstandsmitglied bei MONOPAR THERAPEUTICS INC.
Vermögen: 16 843 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Raymond Anderson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 31 | |
| Public Company | Biotechnology | 10 | |
| Public Company | Biotechnology | 10 | |
Dow Pharmaceutical Sciences, Inc.
 Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA.
3
| Subsidiary | Medical Distributors | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Raymond Anderson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TELIGENT | Pharmaceuticals: Major | Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel General Counsel Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Corporate Officer/Principal Director/Board Member | |
| XOMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| CHIASMA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Mylan Bertek Pharmaceuticals, Inc.
 Mylan Bertek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Mylan Bertek Pharmaceuticals, Inc. is a pharmaceutical company based in Research Triangle Park, NC. The company's focus is not mentioned in the provided metadata, as the description appears to be unrelated and potentially incorrect. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Compliance Officer Director of Finance/CFO | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer General Counsel | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Chairman Corporate Officer/Principal | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Director of Finance/CFO Comptroller/Controller/Auditor | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
Glyko, Inc.
 Glyko, Inc. Medical SpecialtiesHealth Technology Part of BioMarin Pharmaceutical, Inc., Glyko, Inc. discovers, develops, and commercializes carbohydrate enzyme therapeutics. The company is based in Novato, CA. Glyko was acquired by BioMarin Pharmaceutical, Inc. on October 08, 1998 for $14.50 million. | Medical Specialties | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| McGill University | College/University | Graduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Undergraduate Degree | |
| San Francisco State University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Pharmaceuticals: Major | Director/Board Member Chairman President Corporate Officer/Principal Director of Finance/CFO Compliance Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
Innovation Development Institute, Inc.
 Innovation Development Institute, Inc. Electronic Equipment/InstrumentsElectronic Technology Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL. | Electronic Equipment/Instruments | Chairman Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| VIELA BIO, INC. | Biotechnology | President Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
Tactic Pharma LLC
 Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Tactic Pharma LLC is an American company that develops pre-clinical and clinical stage compounds. The private company was founded by Andrew P. Mazar and Chandler Drew Robinson. Chandler Drew Robinson has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| Wilson Therapeutics, Inc. | Director/Board Member Founder | ||
| Chemistry of Life Processes Institute | College/University | Director/Board Member Corporate Officer/Principal | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Chairman |
Statistik
International
| Vereinigte Staaten | 47 |
| Kanada | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 5 |
| Health Services | 2 |
Operativ
| Director/Board Member | 268 |
| Corporate Officer/Principal | 131 |
| Independent Dir/Board Member | 81 |
| Chief Executive Officer | 61 |
| Chairman | 54 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| Timothy Walbert | 40 |
| Georges Gemayel | 33 |
| Llew Keltner | 32 |
| Gregg Lapointe | 25 |
| Erich Sager | 21 |
| Robert A. Heft | 18 |
| Georgia Erbez | 18 |
| Suzanne Bruhn | 18 |
| Rick Franklin | 17 |
| Craig Johnson | 17 |
| Fredric D. Price | 16 |
| Bhaskar Chaudhuri | 16 |
| Krishna R. Polu | 16 |
| Arthur Klausner | 16 |
- Börse
- Insiders
- Raymond Anderson
- Unternehmensverbindungen
